# Kazuhiro Ikumi

> Kazuhiro Ikumi is the Nagoya-based founder and CEO of MEDICOLAB, established in June 2018. He also serves as a part-time MEDISO supporter. His publicly described work spans strategy, business development, intellectual property, finance and hiring.

- **Role:** Founder and CEO at MEDICOLAB
- **Organizations:** MEDICOLAB, MEDISO, Nagoya University, Tohoku University, Juntendo University
- **From:** Takasaki, Japan
- **Education:** Doctor of Medicine (MD), Nagoya University, Two-month exchange placement; not a degree, University of North Carolina at Chapel Hill
- **Known for:** Founded MEDICOLAB in June 2018., Led MEDICOLAB when it received a Fujitsu Best Partner Award 2021., Named project lead in an AMED selection published April 30, 2026; four projects selected from twenty-one applications.

## Career timeline

- **2018-06** — Founded MEDICOLAB in Nagoya.
- **2019** — Participated in the Aichi Accelerator 2018 demo days.
- **2022** — MEDICOLAB named a Fujitsu Best Partner Award 2021 recipient; announcement published February 1, 2022.
- **2023-08** — Began serving as a part-time MEDISO supporter.
- **2024-08** — Started a part-time lecturer role at Tohoku University, according to his LinkedIn profile.
- **2024-08** — Presented at PRE-STATION Ai Pitch & Meetup on August 28.
- **2024-09** — Participated in the September 6 MEDISO panel in Nihonbashi.
- **2025-11** — Started a part-time assistant role at Juntendo University, according to his LinkedIn profile.
- **2026-03** — Presented in the NQ Bio-Catalyst AI Accelerator programme report session.

## Achievements

- Founded MEDICOLAB in June 2018.
- Led MEDICOLAB when it received a Fujitsu Best Partner Award 2021.
- Named project lead in an AMED selection published April 30, 2026; four projects selected from twenty-one applications.

## Latest updates

- **2026-03** — Listed among eleven selected participants presenting at the NQ programme report session on March 5.
- **2026-04** — AMED published a selection naming Ikumi as MEDICOLAB’s project lead.
- **2026-07** — MEDICOLAB announced its AMED grant decision with a subsidy ceiling of approximately JPY 109 million; this is company project support, not personal wealth.
- **2026-09** — The INDEPENDENTS reported that MEDICOLAB was seeking a lead investor for a seed round.

## Links

- LinkedIn: https://jp.linkedin.com/in/kazuhiro-ikumi-8b3120178

---

Profile page: https://yespress.io/kazuhiro-ikumi
Published by YesPress — https://yespress.io
Last updated: 2026-10-21